Re: Re: Replicel OwnershipRPINVESTOR1 posted:
"Not too sure about the rules on a private takeover by insiders. Do they have a vote or do only the non-insiders get to vote?
The interim order describes the process of calling and giving notice of the meeting of securityholders, the conduct of the meeting, and the level of approval by which securityholders of each class must approve the arrangement (generally 66% to 75%, depending on the province of incorporation of the target company and whether the holders of equity securities or creditors of the target will be statutorily required to vote respecting the plan of arrangement). The Court will almost always grant a right of dissent to each securityholder, providing securityholders entitled to vote at the meeting who oppose the proposed transaction to dissent and receive “fair value” for their voting securities as determined by a Court.
Also, has Replicel ever informed the shareholders as to the reason why the Chinese Company has not started the Phase 2 skin and tendon trials. They were very prompt in the construction their laboratory and then no further activity. Does their contract with Replicel contain a clause stating that the trials will not start until Replicel produces a dermal injector approved for sale on the market? "
No, we never hear about Yofoto. I can only imagine how disappointed they are that the Dermal Injector has gone into a stall after all these years. They will not be investing another dime into Replicel until they market the device.